Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-01

Clinical Trial Update: Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on the Protégé EverFlex stent for popliteal lesions in peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Protégé EverFlex Stent

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED